Clinical Trials Research Market Share

  • Report ID: 4215
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Clinical Trials Research Market Share

North America industry is estimated to hold largest revenue share by 2037, attributed to rising number of clinical trial studies in the region. As of 2022, the number projected for medical studies at the end of the year is nearly 55,000, which is an increase from the number of studies conducted in 2021 that were calculated to be around 50,000.  Additionally, rising investment in R&D and developing healthcare infrastructure of the region is further expected to hike the growth of the market over the forecast period.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4215
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of clinical trials is assessed at USD 55.84 billion.

Clinical Trials Market size was valued at USD 52.92 billion in 2024 and is expected to reach USD 120 billion by 2037, registering around 6.5% CAGR during the forecast period i.e., between 2025-2037.

North America industry is estimated to hold largest revenue share by 2037, attributed to rising number of clinical trial studies in the region.

The major players in the market are Clinipace Inc., Parexel International Corporation, Pfizer Inc., PPD Inc., Novo Nordisk A/S, Eli Lilly and Company, GSK plc, Merck & Co., Inc., AstraZeneca plc, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample